Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
06/2004
06/24/2004WO2004025293A3 Antibody for isolating and/or identifying mesenchymal stem cells and method for isolating and/or identifying mesenchymal stem cells
06/24/2004WO2004024883A3 PAKs AS MODIFIERS OF THE CHK PATHWAY AND METHODS OF USE
06/24/2004WO2004024633A3 Dipping sensor for real-time bod monitoring of water
06/24/2004WO2004024026A3 Method and device for monitoring platelet function
06/24/2004WO2004022716A3 Recombinatant mutants of rhabdovirus and methods of use thereof
06/24/2004WO2004022594A3 Immune modulatory compounds and methods
06/24/2004WO2004020653A3 Analytical method for the determination of infant formula protein digestibility in vitro
06/24/2004WO2004019043A3 Polypeptide biomarkers for diagnosing alzheimer's disease
06/24/2004WO2004017922A3 Keto cannabinoids with therapeutic indications
06/24/2004WO2004016227A3 Screening methods for cognitive enhancers
06/24/2004WO2004015379A3 Apparatus and method for quantatively measuring liquid film drying rates on substrates
06/24/2004WO2004012046A3 Method for analyzing readings of nucleic acid assays
06/24/2004WO2004011664A3 Protein or carbohydrate profiling
06/24/2004WO2004007753A3 Transgenic non-human mammals expressing a reporter nucleic acid under the regulation of androgen response elements
06/24/2004WO2004006844A3 Method for identifying salt-sensitive persons
06/24/2004WO2004005474A3 A robust, inducible cardiac preferred expression system for transgenesis
06/24/2004WO2004003683A3 Conformational sampling by self-organization
06/24/2004WO2004003513A3 Compositions and methods for determining the replication capacity of a pathogenic virus
06/24/2004WO2004003507A3 Methods for identifying regulators of muscle mass using amylin receptors
06/24/2004WO2003107004A3 Method for isolating an allosteric effector of a receptor
06/24/2004WO2003097795A3 Constitutively translocating cell line
06/24/2004WO2003093822A3 Device for closure of a vascular defect
06/24/2004WO2003090690A3 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such
06/24/2004WO2003086311A3 Methods for treating tweak-related conditions
06/24/2004WO2003076631A3 Genetic products differentially expressed in tumors and use thereof
06/24/2004WO2003068800A3 Isolated peptides which bind to hla molecules and uses thereof
06/24/2004WO2003049686A3 Stabilization of hypoxia inducible factor (hif) alpha
06/24/2004WO2003048372A3 Methods and apparatus for complex genetics classification based on correspondence analysis and linear/quadratic analysis
06/24/2004WO2003036257A3 Immobilizing biological molecules
06/24/2004WO2003034065A3 Drug rescue by redesign of admet/pk properties
06/24/2004WO2003028271A9 Methods of using quantitative lipid metabolome data
06/24/2004WO2003027264A3 Coisogenic eukaryotic cell collections
06/24/2004WO2003024386A8 Use of potent, selective and non toxic c-kit inhibitors for treating interstitial cystitis
06/24/2004WO2003022028A3 Methods, reagents, kits and apparatus for protein function analysis
06/24/2004WO2003018044A8 New drug
06/24/2004WO2003015613A3 Molecular characteristics of non-small cell lung cancer
06/24/2004WO2002097390A8 A quantitative hybridization assay for the analysis of nucleic acid
06/24/2004WO2002088702A9 Dielelectrophoretic method and apparatus for high throughput screening
06/24/2004WO2001066563A8 T1r taste receptors and genes encoding same
06/24/2004US20040123335 Using peptide mimetics to prevent or treat autoimmune diseases; immunotherapy
06/24/2004US20040123334 Methods of treating neurodegenerative diseases
06/24/2004US20040122857 Secondary structure defining database and methods for determining identity and geographic origin of an unknown bioagent in forensic studies thereby
06/24/2004US20040122299 Method for the skin analysis
06/24/2004US20040122222 Instrument and method for collecting nucleic acids
06/24/2004US20040122221 Comprises nuclelotide sequences which cell proliferative agents for use in identifying modulators for prevention and treatment of cancer and organ rejection
06/24/2004US20040122216 A mutein recombinant tissue protective cytokine lacking at least one activity selected from group consisting of increasing hematocrit, vasoactive action, hyperactivating platelets, pro-coagulant activities and increasing production of thrombocytes
06/24/2004US20040122213 Chlamydia heat shock protein
06/24/2004US20040122059 PPAR-gamma ligands in the treatment of asthma and allergies
06/24/2004US20040121975 Hepatitis C virus assays
06/24/2004US20040121968 Antiangiogenesis by inhibiting protein kinase CK2 activity
06/24/2004US20040121956 For therapy of diseases in animals and for the control of insects that are injurious or harmful to plants or animals
06/24/2004US20040121947 Compounds which inhibit beta-secretase activity and methods of use thereof
06/24/2004US20040121491 for the investigation of ligand-receptor interactions; chemical surface activation and covalent grafting of ATR (Attenuated Total Internal Reflection)-elements and their use in FTIR (Fourier Transform Infra Red) devices; solid phase synthesis
06/24/2004US20040121490 Metal chelate containing compositions for use in chemiluminescent assays
06/24/2004US20040121489 Using prostanoid concentration variations to prognose metabolic disorders secondary to diabetes onset; preventing diabetes associated defects via administration of cyclooxygenase-2 (COX-2) inhibitors
06/24/2004US20040121488 carried out in a low conductivity, water-miscible organic solvent buffer which minimizes heat generation, and permits the analysis of hydrophobic and low molecular weight proteins as well as hydrophilic proteins
06/24/2004US20040121487 Method for enhanced accuracy in predicting peptides using liquid separations or chromatography
06/24/2004US20040121480 Reduction of the hook effect in membrane-based assay devices
06/24/2004US20040121479 Portable pollution control apparatus for detection of toxic gases in exhaust stream from turbines or internal combustion engines
06/24/2004US20040121478 for determining a gas, in particular in air, having a radiation source, a detector and a sensitive layer in the beam path of the radiation source containing acidic or basic side chains
06/24/2004US20040121477 Method for improving data dependent ion selection in tandem mass spectroscopy of protein digests
06/24/2004US20040121476 Quality control material for reagentless measurement of analytes
06/24/2004US20040121475 Indicator for calcium and magnesium
06/24/2004US20040121474 Using moving optical gradients to identify activator/lymphocyte interactions and monitor displacement associated with activated lymphocytes; viral detection, bacterial drug sensitivity, rapid clonal selection and toxicity testing
06/24/2004US20040121473 Determining amount of antipeeling and antiscaling agents in tars; decreasing and/or preventing physical separation and degradation of pavements; prediciting longevity of paved roads
06/24/2004US20040121472 Predictive crude oil compatibility model
06/24/2004US20040121458 Culturable mitochondrial cells with no nucleus, showing mitochondrial activity
06/24/2004US20040121457 Secondary sprouting for isolation and expansion of endothelial sprout cells and endothelial precursor cells from a mixed population and for screening substances
06/24/2004US20040121456 Rapid cell block embedding method and apparatus
06/24/2004US20040121454 Microreactor
06/24/2004US20040121453 Bioreactor and bioprocessing technique
06/24/2004US20040121452 Component for biological or biochemical analysis microfluidic system
06/24/2004US20040121449 Method and apparatus for separation of particles in a microfluidic device
06/24/2004US20040121424 Identifying presence of gramnegative bacteria via propagation in nutrient broth containing chromogenic compounds at temperature sufficient to support colifom growth and not non-coliform bacterial growth, monitor broth for fluorescent signal
06/24/2004US20040121423 preferably a positively charged porous matrix having a negatively charged urea derivative dye on its surface; may further include a peroxide producing signal producing system, e.g., an analyte oxidase and/or peroxidase
06/24/2004US20040121422 Diagnosis and treatment of human kidney diseases
06/24/2004US20040121421 for screening newborns for homocysteinuria; can be performed on very small quantities of blood; solid phase synthesis
06/24/2004US20040121419 Methods of secretory vimentin detection and modulation
06/24/2004US20040121417 Immunoassay method and immunoassay reagent kit to be used therein
06/24/2004US20040121416 Assay
06/24/2004US20040121414 Using transforming growth factor and alpha-fetoprotein expression to detect cell proliferative disorders of liver
06/24/2004US20040121413 Detecting cell proliferative disorders of urogenital system via monitoring expression and concentration of g-protein coupled receptor; gene therapy and antitumor agents; tissue targeted therapy
06/24/2004US20040121411 for monitoring cleavage of beta-amyloid precursor protein (beta APP) by monitoring the fluorescent energy transfer between the adducts; for treating Alzheimer's disease
06/24/2004US20040121408 Microreactor
06/24/2004US20040121407 Regulation of the growth hormone/IGF-1 axis
06/24/2004US20040121406 Methods and formulations for increasing the affinity of a1 adenosine receptor ligands for the a1 adenosine receptor
06/24/2004US20040121405 Selective covalent-binding compounds having therapeutic diagnostic and analytical applications
06/24/2004US20040121404 Staphylococcus aureus-specific detection media and identifying and/or counting method using same
06/24/2004US20040121403 Detection and identification of groups of bacteria
06/24/2004US20040121402 Electrooptic apparatus which exploits antibody diversity for detection of multiple and rare target particles or antigens
06/24/2004US20040121401 Integrated light source for diagnostic arrays
06/24/2004US20040121400 Method and kit for detecting, or determining, 3,4-methylenedioxymethamphetamine
06/24/2004US20040121399 photoactivatible surface bound linker molecules which can be used to fabricate biomolecular arrays
06/24/2004US20040121398 Using oligopeptide models to predict macromolecule binding associations
06/24/2004US20040121397 Using prostate tissue messenger RNA to detect, diagnose, classify, monitor, prognosticate, prevent or treat cell proliferative disorders of urogenital system
06/24/2004US20040121395 Sequence #115 as a target for identifying weight modulating compounds
06/24/2004US20040121393 Using allelic variance in immune response receptors to diagnose and prognose cancer, viral and bacterial infections, glomerulonephritis, sjogren's syndrome and leprosy
06/24/2004US20040121391 Treatment of substrates for immobilizing biomolecules
06/24/2004US20040121390 Using messenger RNA isolated from aberrant or defective tissues as diagnostic probes in disease detection
06/24/2004US20040121382 Multiplexed immunohistochemical assays using molecular tags